Format

Send to

Choose Destination
See comment in PubMed Commons below
BMC Pulm Med. 2013 Mar 28;13:20. doi: 10.1186/1471-2466-13-20.

A randomized, double-blind, placebo-controlled trial of oral montelukast in acute asthma exacerbation.

Author information

1
Section of Pulmonary and Critical Care Medicine, Department of Medicine, The Aga Khan University Hospital, Stadium Road, PO Box 3500, Karachi 74800, Pakistan. ali.zubairi@aku.edu

Abstract

BACKGROUND:

Leukotriene receptor antagonists (LTRAs) are well established in the management of outpatient asthma. However, there is very little information as to their role in acute asthma exacerbations. We hypothesized that LTRAs may accelerate lung function recovery when given in an acute exacerbation.

METHODS:

A randomized, double blind, placebo-controlled trial was conducted at the Aga Khan University Hospital to assess the efficacy of oral montelukast on patients of 16 years of age and above who were hospitalized with acute asthma exacerbation. The patients were given either montelukast or placebo along with standard therapy throughout the hospital stay for acute asthma. Improvements in lung function and duration of hospital stay were monitored.

RESULTS:

100 patients were randomized; their mean age was 52 years (SD +/- 18.50). The majority were females (79%) and non-smokers (89%). The mean hospital stay was 3.70 ± 1.93 days with 80% of patients discharged in 3 days. There was no significant difference in clinical symptoms, PEF over the course of hospital stay (p = 0.20 at day 2 and p = 0.47 at day 3) and discharge (p = 0.15), FEV1 at discharge (p = 0.29) or length of hospital stay (p = 0.90) between the two groups. No serious adverse effects were noted during the course of the study.

CONCLUSION:

Our study suggests that there is no benefit of addition of oral montelukast over conventional treatment in the management of acute asthma attack.

TRIAL REGISTRATION:

TRIAL REGISTRATION NUMBER:

375-Med/ERC-04.

PMID:
23537391
PMCID:
PMC3616955
DOI:
10.1186/1471-2466-13-20
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Support Center